TLV · GEFR.TA
Geffen Residence & Renewal Ltd
₪0.75₪0.00 (0.0%)
Geffen Residence & Renewal Ltd’s quoted price sits in the lower half of its reported 52-week range, 16.55% below the high.
Loading market information…
TLV · DNA.TA · ILA
Stock price, earnings
Quote as of Dec 21, 2025, 01:51 PM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
Dna Group (T.R.) Ltd’s quoted price sits in the lower half of its reported 52-week range, 26.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Dna Group (T.R.) Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Dna Group (T.R.) Ltd, along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of proprietary ultrasound technologies. These advanced systems are utilized to evaluate bone strength and density, as well as to detect and monitor calcium leakage associated with osteoporosis in both adult and pediatric patients. The company's offerings are employed by trained physicians, nurses, and operators within hospitals, clinics, pharmacies, and various other healthcare environments across Israel, North America, East Asia, and international markets. Beyond its core ultrasound business, the group is also involved in the creation of oral medications. Established in 2004 and based in Tel Aviv-Yafo, Israel, the company was formerly known as D.N.A Biomedical Solutions Ltd. before adopting its current name in November 2022.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₪0.75₪0.00 (0.0%)
Geffen Residence & Renewal Ltd’s quoted price sits in the lower half of its reported 52-week range, 16.55% below the high.
₪0.18+₪0.00 (+0.57%)
Bonus BioGroup Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.1% below the high.
₪16.03-₪0.01 (-0.06%)
G.F.C Green Fields Capital Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.96% below the high.
₪10.29+₪0.09 (+0.88%)
Golden House Ltd’s quoted price sits in the lower half of its reported 52-week range, 17.68% below the high.
$2.54-$0.07 (-2.68%)
Enlivex Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
₪27.94₪0.00 (0.0%)
Kadimastem Ltd’s quoted price sits in the lower half of its reported 52-week range, 47.51% below the high.
₪10.20₪0.00 (0.0%)
Rekah Pharmaceutical Industry Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.33% below the high.
₪3.96-₪0.02 (-0.43%)
Pluri Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.42% below the high.
